CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.146
+0.005 (3.26%)
Oct 24, 2024, 4:00 PM EDT - Market closed
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $4.68 million as of October 24, 2024. Its market cap has increased by 8.85% in one year.
Market Cap
4.68M
Enterprise Value
3.16M
1-Year Change
8.85%
Ranking
Category
Stock Price
$0.15
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $71.80M to $4.68M, a decrease of -93.48%. That is a compound annual growth rate of -42.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 5.00M | -25.37% |
| Dec 29, 2023 | 6.70M | 109.38% |
| Dec 30, 2022 | 3.20M | -83.67% |
| Dec 31, 2021 | 19.60M | -33.78% |
| Dec 31, 2020 | 29.60M | -54.46% |
| Dec 31, 2019 | 65.00M | -9.47% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 5.34M |
| Bionomics | 5.28M |
| Biofrontera | 5.28M |
| NLS Pharmaceutics AG | 5.28M |
| Elevai Labs | 5.11M |
| Oncternal Therapeutics | 5.03M |
| Eterna Therapeutics | 4.92M |
| 180 Life Sciences | 4.82M |